The stock of RAPT Therapeutics Inc (RAPT) has seen a -15.68% decrease in the past week, with a -4.17% drop in the past month, and a -19.35% decrease in the past quarter. The volatility ratio for the week is 2.07%, and the volatility levels for the past 30 days are at 11.15% for RAPT. The simple moving average for the past 20 days is -9.22% for RAPT’s stock, with a -30.58% simple moving average for the past 200 days.
Is It Worth Investing in RAPT Therapeutics Inc (NASDAQ: RAPT) Right Now?
Additionally, the 36-month beta value for RAPT is -0.14. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 1 rating it as “overweight,” 4 rating it as “hold,” and 0 rating it as “sell.”
The public float for RAPT is 8.62M and currently, short sellers hold a 8.71% ratio of that float. The average trading volume of RAPT on June 20, 2025 was 117.92K shares.
RAPT) stock’s latest price update
RAPT Therapeutics Inc (NASDAQ: RAPT)’s stock price has decreased by -5.36 compared to its previous closing price of 7.84. However, the company has seen a -15.68% decrease in its stock price over the last five trading sessions. zacks.com reported 2025-06-18 that The consensus price target hints at a 282.7% upside potential for Rapt Therapeutics (RAPT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Analysts’ Opinion of RAPT
Many brokerage firms have already submitted their reports for RAPT stocks, with H.C. Wainwright repeating the rating for RAPT by listing it as a “Buy.” The predicted price for RAPT in the upcoming period, according to H.C. Wainwright is $6 based on the research report published on May 22, 2025 of the current year 2025.
H.C. Wainwright, on the other hand, stated in their research note that they expect to see RAPT reach a price target of $10. The rating they have provided for RAPT stocks is “Buy” according to the report published on December 26th, 2024.
Stifel gave a rating of “Hold” to RAPT, setting the target price at $2 in the report published on November 13th of the previous year.
RAPT Trading at 0.34% from the 50-Day Moving Average
After a stumble in the market that brought RAPT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -75.75% of loss for the given period.
Stock Fundamentals for RAPT
The total capital return value is set at -0.69. Equity return is now at value -75.60, with -67.86 for asset returns.
Based on RAPT Therapeutics Inc (RAPT), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -28.33.
Currently, EBITDA for the company is -126.33 million with net debt to EBITDA at 0.46. The liquidity ratio also appears to be rather interesting for investors as it stands at 21.11.
Conclusion
In conclusion, RAPT Therapeutics Inc (RAPT) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
